Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Mucosal Immunity
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1510766
This article is part of the Research Topic Natural Constituents and Mucosal Immunity: Immune Protection and Treatment of Mucosal Barriers and Microbial Flora Using Omics Technologies and Gene Sequencing View all articles

Herbal HuoXueTongFu Formula with Anti-inflammatory and Fibrinolytic Activity Regulation for the Prevention of Postoperative Peritoneal Adhesions

Provisionally accepted
Yali Wang Yali Wang *Yaoyao Bian Yaoyao Bian Zhengjun Li Zhengjun Li *Ziyang Kong Ziyang Kong *Yanqi Chen Yanqi Chen *Wen Li Wen Li *Huixiang Zhang Huixiang Zhang *Jiafei Wu Jiafei Wu Mingqi Shang Mingqi Shang *Li Zeng Li Zeng *Lili Yang Lili Yang *
  • Nanjing University of Chinese Medicine, Nanjing, China

The final, formatted version of the article will be published soon.

    The HuoXueTongFu Formula (HXTF) originates from the classic prescription ‘DaHuangMuDan Decoction’ from the ‘Synopsis of the golden chamber’. Our previous study revealed that HXTF has a positive effect on postoperative peritoneal adhesion (PPA). However, the specific mechanism of HXTF PPA formation within the time-to-treatment window has not been fully elucidated. This study aimed to determine the critical roles of HXTF as a result of its specific anti-inflammatory and antifibrinolytic activities for PPA treatment. Methods: The eight main bioactive components of HXTF were subjected to high-performance liquid chromatography‒mass spectrometry. The core targets, critical biological processes, and underlying pathways of HXTF and PPA were identified via a series of network pharmacological methods. The specific anti-inflammatory function in the initial step of PPA formation was validated in peritoneal macrophages (PMs) isolated from PPA mice on Day 3 postsurgery. The potential anti-fibrinolytic activity in the next stage of PPA formation was subsequently explored in PPA mice on Day 7 postsurgery. Results: Network pharmacology revealed 160 common targets between HXTF and PPA. Several core targets, i.e., matrix metalloproteinase 9 (MMP9), tissue-type plasminogen activator (tPA), and plasminogen activator inhibitor 1 (PAI-1), were annotated as important biological processes (extracellular matrix disassembly and the collagen catabolic process). Validation experiments revealed that HXTF could induce macrophage polarization-mediated anti-inflammatory reactions by increasing the phagocytic capacity of PMs and promoting the release of anti-inflammatory cytokines (IL-4 and IL-10). In addition, HXTF promoted fibrinogenolysis and improved fibrinolytic activity, thereby inhibiting collagen deposition and reducing adhesion development. Conclusion: The ameliorative effects of herbal HXTF on PPA formation are attributable to the induction of macrophage polarization-mediated anti-inflammatory reactions in the early stage of PPA formation and the promotion of fibrinogenolysis and fibrinolytic activity in the middle stage of PPA formation. HXTF may be a promising alternative agent for the prevention and treatment of PPA.

    Keywords: HuoXueTongFu Formula, Postoperative peritoneal adhesion, Macrophage polarization, fibrinolytic activity, time window

    Received: 13 Oct 2024; Accepted: 24 Dec 2024.

    Copyright: © 2024 Wang, Bian, Li, Kong, Chen, Li, Zhang, Wu, Shang, Zeng and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yali Wang, Nanjing University of Chinese Medicine, Nanjing, China
    Zhengjun Li, Nanjing University of Chinese Medicine, Nanjing, China
    Ziyang Kong, Nanjing University of Chinese Medicine, Nanjing, China
    Yanqi Chen, Nanjing University of Chinese Medicine, Nanjing, China
    Wen Li, Nanjing University of Chinese Medicine, Nanjing, China
    Huixiang Zhang, Nanjing University of Chinese Medicine, Nanjing, China
    Mingqi Shang, Nanjing University of Chinese Medicine, Nanjing, China
    Li Zeng, Nanjing University of Chinese Medicine, Nanjing, China
    Lili Yang, Nanjing University of Chinese Medicine, Nanjing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.